Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 6:14:1695559.
doi: 10.3389/fcell.2026.1695559. eCollection 2026.

Bioinspired artificial nanovesicles engineered from 3D spheroid-cultured UC-MSCs enhance angiogenic activity in vitro: functional proof-of-concept for ischemic applications

Affiliations

Bioinspired artificial nanovesicles engineered from 3D spheroid-cultured UC-MSCs enhance angiogenic activity in vitro: functional proof-of-concept for ischemic applications

Prakash Gangadaran et al. Front Cell Dev Biol. .

Abstract

Artificial nanovesicles (aNVs) derived from cells may mimic naturally secreted extracellular vesicles (EVs) and are becoming popular in biomedical research. We isolated aNVs from two-dimensional (2D)- and three-dimensional (3D)-cultured umbilical cord-derived mesenchymal stem cells (UC-MSCs) (aNVs2D and aNVs3D, respectively) and characterized them using Western blotting and electron microscopy. The aNVs3D showed higher expression of IL-6 and SDF-1α than aNVs2D. In vitro treatment with aNVs2D and aNVs3D resulted in their internalization into endothelial cells and the subsequent alteration of endothelial cell proliferation, migration, and tube formation. Both aNVs were positive for EVs and cell markers and were round in shape. Furthermore, aNVs3D treatment enhanced endothelial cell proliferation, migration, and tube formation more effectively than aNVs2D treatment. Our study demonstrates that aNVs3D are potent inducers of angiogenesis, indicating their potential in cell-free ischemia treatment.

Keywords: angiogenesis; artificial nanovesicles; ischemia; mesenchymal stem cells; three-dimensional.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

None
Graphical abstract
FIGURE 1
FIGURE 1
Establishment of 2D and 3D Cultures of Umbilical Cord-Derived Mesenchymal Stem Cells. (A) Schematic representation of 2D and 3D UC-MSC cultures, created with BioRender.com. (B) Images of 2D cultures of MSCs (UC-MSCs2D) in flat bottom plates and 3D cultures of MSCs (UC-MSCs3D) in U-shaped 96-well plates, with UC-MSCs3D cultured up to day 5 (scale bar: 500 pixels).
FIGURE 2
FIGURE 2
Generation and Characterization of aNVs2D and aNVs3D. (A) Graphical illustration of the generation of aNVs2D and aNVs3D from UC-MSCs2D and UC-MSCs3D, respectively, created with BioRender.com. (B) Western blot analysis of aNVs2D and aNVs3D (10 µg protein per lane) using antibodies against ALIX, CD63, flotillin-1, and calnexin. (C) TEM imaging of aNVs2D and aNVs3D (scale bar: 200 nm). (D) An array blot incubated with aNVs2D and aNVs3D lysate (50 µg per blot), the fold change of highly expressed cytokines was presented in graph.
FIGURE 3
FIGURE 3
Internalization of aNVs2D and aNVs3D into Endothelial Cells. Fluorescence microscopy images demonstrate the internalization of aNVs2D (DiD) and aNVs3D (DiD) into endothelial cells (scale bar: 20 µm).
FIGURE 4
FIGURE 4
aNVs3D Promoted the Proliferation and Migration of Endothelial Cells. (A) Endothelial cells were treated with aNVs2D and aNVs3D (0, 2.5, 5, and 10 μg/mL) for 12 h and 24 h, and cell proliferation (n = 4) was assessed using the CCK-8 assay. (B) Illustration of the experiment to assess endothelial cell migration following treatment with aNVs, created with BioRender.com. (C) Representative image of transwell migration of endothelial cells treated with aNVs2D and aNVs3D (5 and 10 μg/mL) at 12 h and 24 h (scale bar: 100 µm). (D) Quantitative analysis of the transwell migration assay presented in (C) (n = 3). Statistical significance is denoted as follows: *p < 0.05; **p < 0.01, ***p < 0.001 and ****p < 0.0001, as determined by Two-way ANOVA.
FIGURE 5
FIGURE 5
aNVs3D Promoted Vessel-Like Tube Formation In Vitro. (A,B) Representative microscopic images showing vessel-like tube formation by endothelial cells treated with aNVs2D and aNVs3D in Matrigel (scale bar: 100 µm) at 3 h and 6 h (C,D) Quantification of % of vessel percentage area total vessel area, junctions density, and total vessels length analyzed using AngioTool for (A) (n = 3). Statistical significance determined by Student’s t-test is denoted as follows. ns: no significance, *p: <0.05, and **p: <0.01.

References

    1. Ababneh N. A., Alwohoush E., AlDiqs R., Ismail M. A., Al-Kurdi B., Barham R., et al. (2025). Impact of differentiation protocols on the functionality of mesenchymal stem cells derived from induced pluripotent stem cells. World J. Stem Cells 17 (12), 110564. 10.4252/wjsc.v17.i12.110564 - DOI - PMC - PubMed
    1. Antoni D., Burckel H., Josset E., Noel G. (2015). Three-dimensional cell culture: a breakthrough in vivo . Int. J. Mol. Sci. 16 (3), 5517–5527. 10.3390/ijms16035517 - DOI - PMC - PubMed
    1. Arabzadeh A., Faghfuri E., Razi Soofiyani S., Dalir Abdolahinia E., Siapush S., Nejati-Koshki K., et al. (2023). Current and novel emerging medical therapies for peripheral artery disease: a literature review. Adv. Pharm. Bull. 13 (2), 259–268. 10.34172/apb.2023.025 - DOI - PMC - PubMed
    1. Chaicharoenaudomrung N., Kunhorm P., Noisa P. (2019). Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling. World J. Stem Cells 11 (12), 1065–1083. 10.4252/wjsc.v11.i12.1065 - DOI - PMC - PubMed
    1. Che Shaffi S., Hairuddin O. N., Mansor S. F., Syafiq T. M. F., Yahaya B. H. (2024). Unlocking the potential of extracellular vesicles as the next generation therapy: challenges and opportunities. Tissue Eng. Regen. Med. 21 (4), 513–527. 10.1007/s13770-024-00634-4 - DOI - PMC - PubMed

LinkOut - more resources